BioPharmSignal logoBioPharmSignal

Company Profile

Senseonics Stock Price, News & Catalysts

Ticker:
SENS
Exchange:
NYSE
Sector:
Biopharma
Location:
United States

Stock performance

8.03 USD (+2.82%)

Close

Last updated: August 17, 2026

359M USD

Market cap

Why the stock is moving

As of Aug 17, 2026, SENS closed up 2.82% at $8.03. No new same-company headline was identified in the current news window.

Company overview

Implantable Glucose Monitoring

Senseonics develops long-term implantable continuous glucose-monitoring systems for people with diabetes. Its technology places a fluorescence-based sensor under the skin rather than relying on frequently replaced transcutaneous sensors.

Eversense 365

Eversense 365 is designed to provide up to one year of continuous glucose data from a single implanted sensor. A removable external transmitter powers the sensor and sends readings and alerts to a mobile application. Senseonics manufactures the system and now directly manages U.S. commercialization. The company is also transitioning more international sales and marketing activities in-house.

Future catalysts

    Recent news

    1. 01

      Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results

    2. 02

      Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense® 365

    3. 03

      Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

    4. 04

      Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

    5. 05

      Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    DXCM

    DexCom, Inc.

    NMRD

    Nemaura Medical

    EMBC

    Embecta

    MODD

    Modular Medical

    IRMD

    iRadimed

    RMD

    ResMed

    TMCI

    Treace Medical Concepts

    TCMD

    Tactile Systems Technology, Inc.

    Frequently Asked Questions

    What is the current stock price of Senseonics (SENS)?

    Senseonics (SENS) most recently closed at 8.03 USD, a +2.82% move versus the previous session.

    What is the market cap of Senseonics (SENS)?

    Senseonics currently has a market capitalization of 359M USD on BioPharmSignal.

    What does Senseonics do?

    Implantable Glucose Monitoring Senseonics develops long-term implantable continuous glucose-monitoring systems for people with diabetes. Its technology places a fluorescence-based sensor under the skin rather than relying on frequently replaced transcutaneous sensors. Eversense 365 Eversense 365 is designed to provide up to one year of continuous glucose...

    On which exchange is SENS stock listed?

    Senseonics (SENS) is associated with NYSE, United States, Biopharma.

    What is Implantable?

    Implantable Glucose Monitoring Senseonics develops long-term implantable continuous glucose-monitoring systems for people with diabetes.

    Which conditions is Senseonics targeting with Implantable?

    Senseonics is associated with diabetes based on its company overview and current catalyst commentary.

    What is Glucose?

    Implantable Glucose Monitoring Senseonics develops long-term implantable continuous glucose-monitoring systems for people with diabetes.

    What is Monitoring?

    Implantable Glucose Monitoring Senseonics develops long-term implantable continuous glucose-monitoring systems for people with diabetes.